Categories
Stocks News Business News Global News Market News Earnings News IPO News
Quick Links
Ongoing IPO's Upcoming IPO's Closed IPO's Research Call's

sandoz

  1. K

    Lupin Secures European Commission Approval for Ranluspec Biosimilar to Treat Eye Disorders

    New Delhi, February 23Drug maker Lupin on Monday announced that it has received approval from the European Commission for its biosimilar Ranluspec, used in the treatment of several serious eye conditions.The approval follows a recent positive opinion from the Committee for Medicinal Products...
    • Karthik
    • Thread
    • age-related macular degeneration biosimilar bse choroidal neovascularization diabetic macular edema european commission eye conditions germany lupin macular edema pharmaceuticals proliferative diabetic retinopathy ranibizumab sandoz thierry volle
    • Replies: 0
    • Forum: Business
Back
Top